Grants and Contributions:
Title:
Unified Parameter Filtering across Disparate Business Intelligence & Analytics Systems
Agreement Number:
970132
Agreement Value:
$150,000.00
Agreement Date:
Apr 1, 2021 - Feb 28, 2023
Description:
This project will deliver the industry’s first, unified filtering mechanism, applicable across disparate Business Intelligence (BI) and Analytics platforms (BI&A). The benefactors of this project will be end users that are required to work with multiple BI&A solutions in order to effectively analyze corporate date. Users will be able to simultaneously analyze data across disparate systems replacing the current way that this type of analysis is performed, which consists of repetitive, error prone, manual interactions.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1N 5W1
Reference Number:
172-2021-2022-Q1-970132
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
802211185
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 151 days.
Amendment Date
Sep 21, 2022
Recipient's Operating Name:
Theia Canada
Recipient's Legal Name:
Theia Canada Software Inc.
Federal Riding Name:
Ottawa--Vanier
Federal Riding Number:
35078
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
5112
Amendments: